Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloomberg News reports - Headlines news and analysis from Global Banking & Finance Review

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Headlines

Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloomberg News reports

Published by Global Banking & Finance Review

Posted on October 30, 2025

1 min read

· Last updated: October 30, 2025

Add as preferred source on Google

innovation financial community corporate strategy

Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloombe...

Novo Nordisk's Strategic Move in the Pharmaceutical Market

(Reuters) -Danish drugmaker Novo Nordisk has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications, Bloomberg News reported on Thursday citing people with knowledge of the matter.

Details of the Bid

(Reporting by Sriparna Roy in Bengaluru; Editing by Mrigank Dhaniwala)

Key Takeaways

Novo Nordisk has increased its bid for Metsera.
The move is aimed at challenging Pfizer's existing deal.
Novo Nordisk seeks to strengthen its weight-loss medication market.
The news was reported by Bloomberg citing insider sources.
This strategic bid highlights competition in pharmaceuticals.

Frequently Asked Questions

What is a bid?

A bid is an offer made by an individual or company to purchase an asset or service at a specified price. In finance, bids are often used in auctions or competitive purchasing situations.

What is a pharmaceutical market?

The pharmaceutical market refers to the industry involved in the research, development, production, and marketing of medications. It includes both prescription and over-the-counter drugs.

What is weight-loss medication?

Weight-loss medications are drugs designed to help individuals lose weight by suppressing appetite, increasing feelings of fullness, or reducing absorption of calories. They are often prescribed alongside lifestyle changes.

More from Headlines

Explore more articles in the Headlines category

Trump announces three-day ceasefire between Ukraine and Russia

Palestinian American developer asks US judge to dismiss lawsuit alleging he aided Hamas

Greece investigating Ukrainian-made naval drone found in cave at island

Rubio says US ties with Church can withstand Trump's criticism of Pope Leo

Hantavirus cruise ship part of Antarctic tourism boom that some want better regulated

Russia says radiation levels are normal after fires near Chornobyl

UK man denies charge of threatening King Charles' brother Andrew

Norway police hold Chinese woman in custody over suspected espionage

Ukraine weighs sending security experts to Baltic states amid drone incidents

UK's Princess Kate to visit pioneering Italian schools funded by WW2 scrap metal

Meloni meets Rubio as Iran war strains Italy-US ties

Pope Leo, after Rubio meeting, asks God to inspire leaders to calm tensions

View All Headlines Posts

Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloomberg News reports

Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloombe...

Novo Nordisk's Strategic Move in the Pharmaceutical Market

Details of the Bid

Key Takeaways

Frequently Asked Questions

Tags

Related Articles

Indonesia locates two Singaporeans missing after Mount Dukono eruption

Analysis-Trump's feuds, tensions with allies likely to outlast Iran war

US arranging repatriation for Americans on cruise ship hit by hantavirus

North Korean leader Kim calls ties with Russia top priority in Victory Day message to Putin

US revises UN resolution on Iran but China, Russia still expected to veto

Ukraine's Zelenskiy confirms US announcement of ceasefire, prisoner exchange

More from Headlines